These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16344847)

  • 1. The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives.
    Ribeiro R; Lopes C; Medeiros R
    Prostate Cancer Prostatic Dis; 2006; 9(1):19-24. PubMed ID: 16344847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and prostate cancer: epidemiology and clinical implications.
    Buschemeyer WC; Freedland SJ
    Eur Urol; 2007 Aug; 52(2):331-43. PubMed ID: 17507151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and prostate cancer: a role for adipokines.
    Mistry T; Digby JE; Desai KM; Randeva HS
    Eur Urol; 2007 Jul; 52(1):46-53. PubMed ID: 17399889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and prostate cancer.
    O'Malley RL; Taneja SS
    Can J Urol; 2006 Apr; 13 Suppl 2():11-7. PubMed ID: 16672123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, adipokines, and prostate cancer (review).
    Baillargeon J; Rose DP
    Int J Oncol; 2006 Mar; 28(3):737-45. PubMed ID: 16465380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
    Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
    Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells.
    Hoda MR; Popken G
    BJU Int; 2008 Aug; 102(3):383-8. PubMed ID: 18341625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
    Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin and prostate: implications for cancer prevention--overview of genetics and molecular interactions.
    Ribeiro R; Lopes C; Medeiros R
    Eur J Cancer Prev; 2004 Oct; 13(5):359-68. PubMed ID: 15452447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are findings from studies of obesity and prostate cancer really in conflict?
    Freedland SJ; Giovannucci E; Platz EA
    Cancer Causes Control; 2006 Feb; 17(1):5-9. PubMed ID: 16411047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.
    Fowke JH; Motley SS; Wills M; Cookson MS; Concepcion RS; Eckstein CW; Chang SS; Smith JA
    Cancer Causes Control; 2007 May; 18(4):375-84. PubMed ID: 17334811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
    Bonkhoff H; Berges R
    Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows".
    Kaaks R; Stattin P
    Cancer Prev Res (Phila); 2010 Mar; 3(3):259-62. PubMed ID: 20179295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
    Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
    Cancer; 2007 Mar; 109(6):1192-202. PubMed ID: 17311344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer.
    Skolarus TA; Wolin KY; Grubb RL
    Nat Clin Pract Urol; 2007 Nov; 4(11):605-14. PubMed ID: 17982437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.